Case report reveals discordant HbA1c in a patient with normal fasting plasma glucose, indicating assay interference may affect management decisions.
Hemoglobin A1c (HbA1c) reflects average glycemia over approximately two to three months and is widely used for the diagnosis and monitoring of diabetes mellitus; however, discordant results may occur due to analytical interference, altered erythrocyte turnover, or preanalytical factors. We report a 31-year-old male with no known history of diabetes who presented for routine laboratory evaluation and was found to have an HbA1c of 13.9% despite a normal fasting plasma glucose of 89 mg/dL. Repeat testing of the same sample six hours later demonstrated a decrease to 7.5%, and a simultaneously collected new sample yielded an identical value. Over subsequent days, repeated measurements across multiple samples showed further decline and eventual stabilization at 5.8%. The patient remained asymptomatic, and additional evaluation did not support persistent hyperglycemia. Urine toxicology screening was positive for opioids, and the patient reported recent use of an unidentified substance. A follow-up sample obtained after two weeks confirmed a stable HbA1c of 5.8%. The rapid intra-sample variability and subsequent normalization observed in this case are inconsistent with the known kinetics of hemoglobin glycation and strongly suggest a non-physiological mechanism, most likely assay interference. This case emphasizes the importance of verifying unexpected HbA1c results prior to clinical decision-making to avoid misdiagnosis and inappropriate management.
No takes yet. Share an insight, caveat, or question.
Elkhider et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: